InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Releases FY 2022 Financial, Corporate Report
Dec 14, 2022
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has filed its audited financial statements and is reporting on corporate highlights for the fiscal year ending Aug. 31, 2022. Highlights include the World Intellectual Property Organization publishing TRYPF’s international PCT patent application, which covers the intravenous administration of psilocybin and psilocin. The patent is connected to Tryp’s development of TRP-8803, an intravenous infusion of psilocin designed to significantly reduce the time to onset of the psychedelic state, control the depth and duration of the psychedelic experience, and reduce the overall duration of the intervention to a commercially feasible timeframe. Other highlights include the filing of provisional patents for the use of psilocybin for the treatment of patients with binge eating disorder and for the treatment of patients with fibromyalgia. The report also noted the filing of a provisional patent for crystalline forms of TRP-8803. In addition, Tryp started preparations for a phase 2a trial using TRP-8802 to evaluate psilocybin-assisted therapy among patients with fibromyalgia. “Tryp has continued to execute its multipronged strategy of exploring the clinical utility of psilocybin-assisted psychotherapy, expanding its IP portfolio, and advancing TRP-8803 (IV-infused psilocin), the company’s proprietary and eventual commercial product,” said Tryp Therapeutics CEO Jim Gilligan in the press release. “To that end, Tryp expects to have the interim results from our phase 2a clinical binge eating disorder trial as early as January 2023 and has submitted several provisional patents related to fibromyalgia, binge eating disorder, and co-formers of TRP-8803. Furthermore, the company has completed a series of pharmacology and toxicology programs necessary to advance TRP-8803 into the clinic. With a burgeoning pipeline and a variety of novel and impactful provisional patents in place, we look forward to continuing to execute our business plan in 2023 and beyond.”
To view the full release, visit https://ibn.fm/rqUez
About Tryp Therapeutics Inc.
Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) for the potential treatment of eating disorders, chronic pain, and other indications. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.
NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork
More News
Travel influencer reveals five clever tricks to squeeze more out of your next city break
A travel influencer has revealed five surprisingly simple tricks to squeeze more out of a city break, without spending a penny extra. Nesha Woolery, 32, known online as @travelwithnesha_ from Birmingham, says a handful of clever habits can save travellers precious time, leaving them free to explore more, see more and make the most of every minute away.
Glassmaker Maximilian Riedel on His Travel Tips, and Not Drinking When Flying
Work takes Austrian glassmaker Maximilian Riedel all around the globe. His surprising hot take? Don’t drink when flying… The post Glassmaker Maximilian Riedel on His Travel Tips, and Not Drinking When Flying appeared first on Business Traveller.
Hong Kong pianist John Lee does justice to Rachmaninov and more despite dry acoustics
The marketing of classical music concerts has increasingly focused on the musician rather than the music, with the often ephemeral cult of personality perceived as more valuable than the notes they play, at least in drawing an audience. So, it was refreshing to hear the fine young musician John Lee play. After studying at the Hong Kong Academy for Performing Arts, where he is now a member of the faculty, Lee earned a master’s degree from the Royal College of Music in London with distinction and...
'No one is safe' as Ebola outbreak surges to more than 10,000 cases, Africa's top doctor warns Canada
Africa's top doctor, who has called Canada home since 2013, tells CBC News there could be "massive" cross-border spread of Ebola in the months ahead as he calls for more international support.
Why GLP-1 users’ impact on food-inspired fragrance market is nothing to sniff at
From cherry and banoffee pie to Tabasco and sesame, the list of food aromas popping up in luxury fragrances keeps growing. Now some perfume makers are starting to ask if weight-loss drugs might be reshaping what consumers want in a scent. So-called gourmand fragrances like Thierry Mugler’s pioneering candyfloss-inspired Angel and Nina Ricci’s toffee apple scent Nina have been around for decades. More recent growth in the segment has been attributed to the Covid-19 pandemic-era boom in online...
Autumn in Beijing, with more than leaves on the agenda
Autumn in Beijing, with more than leaves on the agenda
Non-Americans Are Sharing The Misconceptions They Had About The US Before Visiting, And I'm Laughing At A Lot Of These
"You can get a flu shot, a bottle of tequila, a Snickers bar, and pizza pockets all in the same place." View Entire Post ›
38 Travel Products To Pick Up NOW So You Aren’t In A Pinch Two Days Before Your Departure
Because spending an exorbitant amount of money on a universal adapter at the airport is NOT the vibe. View Entire Post ›
How betel nut chewing in China became a habit for millions, from emperors to commoners
The history of the betel nut, also known as the areca nut, stretches further back than previously thought. New research suggests that people on the Indonesian island of Sulawesi were enjoying its mind-altering effects as long as 25,000 years ago. The discovery began with two ancient skeletons whose teeth bore curious, deep grooves. Australian archaeologists suspected these were the result of repeatedly sucking on whole betel nuts. Chemical analysis subsequently detected traces of arecoline, the...
Yams vs sweet potatoes: the difference, nutrition and how to cook them
Widely known as Sam the Cooking Guy, Sam Zien is an enthusiastic proponent of sweet potatoes. He loves mashing them and seasoning with miso, butter and chopped spring onions. Or he cubes, boils and roasts the sweet potatoes, then adds a generous dollop of lemon yogurt, with sprinkles of dukkah, a mixture of chopped nuts and sesame seeds, seasoned with cumin, coriander and salt. Another way is to add sweet potatoes to quesadillas with Mexican chorizo, a highly seasoned fatty pork sausage, and...
10 expert tips to help you wake up in the winter feeling refreshed, happy and energised
As winter draws closer in some places and darker mornings become part of the daily routine, getting out of bed can feel more difficult than ever. Psychotherapist Shazna Khanom, head of clinical mental health at healthcare company Bupa in the UK, explains that the shorter days and reduction of daylight during autumn and winter can have a significant impact on our energy levels. “The darkness doesn’t just impact people’s mood – it can also change their energy levels and make them feel slower,” she...
Meet Sylvester Stallone’s youngest daughter, Scarlet Rose, who plays Spencer in Tulsa King
Taylor Sheridan’s hit crime drama Tulsa King is back with its fourth season, and is already the talk of Tinseltown. Led by Sylvester Stallone as Dwight “The General” Manfredi, a New York mafia capo who builds his own syndicate in Tulsa, Oklahoma, it is the most-watched television show on Paramount+ at the time of writing, according to FlixPatrol, and has already been renewed for a fifth season, per TVLine. Sharing the screen with Stallone are Martin Starr, Jay Will and Vincent Piazza, as well...
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.